These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 3816491)

  • 1. Indomethacin therapy in premature infants with patent ductus arteriosus and oliguria.
    Yeh TF; Wilks A; Luken J; Pildes RS
    Dev Pharmacol Ther; 1986; 9(6):369-74. PubMed ID: 3816491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Furosemide prevents the renal side effects of indomethacin therapy in premature infants with patent ductus arteriosus.
    Yeh TF; Wilks A; Singh J; Betkerur M; Lilien L; Pildes RS
    J Pediatr; 1982 Sep; 101(3):433-7. PubMed ID: 7108667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of ibuprofen and indomethacin for closure of patent ductus arteriosus.
    Van Overmeire B; Smets K; Lecoutere D; Van de Broek H; Weyler J; Degroote K; Langhendries JP
    N Engl J Med; 2000 Sep; 343(10):674-81. PubMed ID: 10974130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting oliguria following indomethacin for treatment of patent ductus arteriosus.
    Barrington KJ; Fox M
    Am J Perinatol; 1994 May; 11(3):220-2. PubMed ID: 8048989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Indomethacin and the preterm infant with a patent ductus arteriosus: relationship between plasma concentration and ductus closure.
    Friedman CA; Parks BR; Rawson JE; Serwer GA; Anderson PA
    Dev Pharmacol Ther; 1982; 4(1-2):37-46. PubMed ID: 7117089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Furosemide for symptomatic patent ductus arteriosus in indomethacin-treated infants.
    Brion LP; Campbell DE
    Cochrane Database Syst Rev; 2001; (3):CD001148. PubMed ID: 11686979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Furosemide for symptomatic patent ductus arteriosus in indomethacin-treated infants.
    Brion LP; Campbell DE
    Cochrane Database Syst Rev; 2000; 2001(2):CD001148. PubMed ID: 10796253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of adverse renal reactions to prolonged indomethacin therapy in preterm infants with persistent ductus arteriosus.
    Seyberth HW; Rascher W; Wille L; Hackenthal E; Ulmer HE
    Pediatr Pharmacol (New York); 1983; 3(3-4):259-66. PubMed ID: 6377215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Indomethacin tocolysis increases postnatal patent ductus arteriosus severity.
    Hammerman C; Glaser J; Kaplan M; Schimmel MS; Ferber B; Eidelman AI
    Pediatrics; 1998 Nov; 102(5):E56. PubMed ID: 9794986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of patent ductus arteriosus in preterm infants].
    Jaso E; Tejedor JC; Quero J; Pérez Rodríguez J; Agustí B; Castro J; García Frías E
    An Esp Pediatr; 1982 Jun; 16(6):449-58. PubMed ID: 7125398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Furosemide in indomethacin-treated infants--systematic review and meta-analysis.
    Brion LP; Campbell DE
    Pediatr Nephrol; 1999 Apr; 13(3):212-8. PubMed ID: 10353408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Therapeutic problems with indomethacin in preterm infants with persistent ductus arteriosus].
    Seyberth HW; Müller H; Wille L; Plückthun H; Ulmer HE; Wolf D
    Monatsschr Kinderheilkd; 1983 Feb; 131(2):71-6. PubMed ID: 6843560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolonged versus short course of indomethacin for the treatment of patent ductus arteriosus in preterm infants.
    Herrera C; Holberton J; Davis P
    Cochrane Database Syst Rev; 2004; (1):CD003480. PubMed ID: 14974018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of dopamine for the prevention of the renal side effects of indomethacin in premature infants with patent ductus arteriosus.
    Seri I; Tulassay T; Kiszel J; Csömör S
    Int J Pediatr Nephrol; 1984 Dec; 5(4):209-14. PubMed ID: 6397454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors associated with permanent closure of the ductus arteriosus: a role for prolonged indomethacin therapy.
    Quinn D; Cooper B; Clyman RI
    Pediatrics; 2002 Jul; 110(1 Pt 1):e10. PubMed ID: 12093991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recurrence of symptomatic patent ductus arteriosus in extremely premature infants, treated with indomethacin.
    Mellander M; Leheup B; Lindstrom DP; Palme C; Graham TP; Stahlman MT; Cotton RB
    J Pediatr; 1984 Jul; 105(1):138-43. PubMed ID: 6737129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Late closure of the ductus arteriosus using indomethacin in the preterm infant.
    Kresch MJ; Moya FR; Ascuitto RJ; Ross-Ascuitto NT; Heusser F
    Clin Pediatr (Phila); 1988 Mar; 27(3):140-3. PubMed ID: 3342597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of oral ibuprofen and intravenous indomethacin for closure of patent ductus arteriosus in preterm infants.
    Chotigeat U; Jirapapa K; Layangkool T
    J Med Assoc Thai; 2003 Aug; 86 Suppl 3():S563-9. PubMed ID: 14700149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral ibuprofen and indomethacin for treatment of patent ductus arteriosus in premature infants: a randomized trial at Ramathibodi Hospital.
    Supapannachart S; Limrungsikul A; Khowsathit P
    J Med Assoc Thai; 2002 Nov; 85 Suppl 4():S1252-8. PubMed ID: 12549803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Indomethacin for closure of patent ductus arteriosus in prematures.
    Mullett MD; Croghan TW; Myerberg DZ; Krall JM; Neal WA
    Clin Pediatr (Phila); 1982 Apr; 21(4):217-20. PubMed ID: 7039927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.